kigelia africana leaf extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identified for kigelia africana leaf extract. Peer‑reviewed literature reports pharmacological and topical activities (antioxidant, antimicrobial, anti‑inflammatory) but no animal or human reproductive toxicity or teratogenicity data were found, therefore no evidence of reproductive hazard; topical use would be expected to give low but measurable dermal exposure in adults (low systemic absorption typical for botanical extracts) (sources: PubMed, PubChem, ECHA C&L, CosIng).
Related ingredients
Frequently asked questions
- kigelia africana leaf extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identified for kigelia africana leaf extract. Peer‑reviewed literature reports pharmacological and topical activities (antioxidant, antimicrobial, anti‑inflammatory) but no animal or human reproductive toxicity or teratogenicity data were found, therefore no evidence of reproductive hazard; topical use would be expected to give low but measurable dermal exposure in adults (low systemic absorption typical for botanical extracts) (sources: PubMed, PubChem, ECHA C&L, CosIng).
- kigelia africana leaf extract emzirirken güvenli mi?
- No data indicating reproductive or lactation toxicity or breastmilk transfer. In absence of evidence for systemic reproductive toxicity, hazard and mechanism are scored 0; low but measurable systemic exposure from topical use is plausible, so exposure scored as low (adult topical exposure) (sources: PubMed, PubChem, ECHA C&L, CosIng).
- kigelia africana leaf extract bebek cildi için güvenli mi?
- No infant‑specific safety or developmental toxicity data were identified. Hazard and mechanism remain 0 due to lack of evidence for reproductive/endocrine effects. Exposure for baby skin is increased relative to adults because of thinner/immature barrier and higher surface‑area‑to‑weight; therefore exposure is elevated to moderate for 0–3 yr (adult low exposure +1) (sources: PubMed, PubChem, CosIng, ECHA C&L).
- VeriMom kigelia africana leaf extract nasıl puanlıyor?
- VeriMom kigelia africana leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte kigelia africana leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.